InhaleRx Limited (ASX:IRX)
Australia · Delayed Price · Currency is AUD 0.0250
0.00 (0.00%)
Jan 30, 2026, 11:09 AM AEST
InhaleRx Revenue
InhaleRx had revenue of 557.12K AUD in the half year ending June 30, 2025, with 27.13% growth. This brings the company's revenue in the last twelve months to 833.90K, down -6.39% year-over-year. In the year 2024, InhaleRx had annual revenue of 401.81K, down -66.63%.
Revenue (ttm)
833.90K
Revenue Growth
-6.39%
P/S Ratio
7.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 401.81K | -802.24K | -66.63% |
| Dec 31, 2023 | 1.20M | 1.18M | 4,755.02% |
| Dec 31, 2022 | 24.80K | -156.94K | -86.35% |
| Dec 31, 2021 | 181.74K | 159.61K | 721.35% |
| Dec 31, 2020 | 22.13K | -110.85K | -83.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chimeric Therapeutics | 12.68M |
| Immuron | 7.29M |
| Biotron | 1.81M |
| Acrux | 1.19M |
| Anatara Lifesciences | 969.46K |
| Patrys | 828.54K |
| AdAlta | 677.01K |
| Bio-Gene Technology | 524.37K |